Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.
Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.
Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.
By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.
An individual named Daren Shaw filed a notice of proposed sale of restricted or control securities under Rule 144. The filing covers 1,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $213,430.00.
The shares come from multiple restricted stock vesting events between 2018 and January 2026, each received as compensation from the issuer. The filing also notes that Shaw sold 1,000 common shares on 11/18/2025 for $178,570.00 in gross proceeds during the prior three months.
Wasatch Advisors reports a significant institutional stake in Ensign Group Inc/The common stock. The firm beneficially owns 2,838,566 shares, representing 4.9% of the outstanding common stock as of 12/31/2025.
Wasatch Advisors has sole voting power over 1,865,171 shares and sole dispositive (selling) power over the full 2,838,566 shares, with no shared voting or dispositive authority. The firm certifies the position is held in the ordinary course of business and not to influence control of Ensign Group.
The Ensign Group director Ann Scott Blouin reported selling 375 shares of common stock on February 9, 2026. The shares were sold at a price of $198 per share under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025.
After this transaction, Blouin beneficially owned 22,852 Ensign Group shares, held in direct ownership. The filing reflects a planned, programmatic sale by a board member rather than a discretionary, one-time trade.
The Ensign Group director Mark Vincent Parkinson reported a small pre-planned stock sale. On February 9, 2026, he sold 100 shares of Ensign Group common stock at $198 per share under a Rule 10b5-1 trading plan adopted on November 6, 2025. After this transaction, he directly beneficially owned 2,900 shares of Ensign Group common stock.
Ensign Group, Inc. CFO and director Suzanne D. Snapper reported stock option exercises and related common stock sales. On February 5–6, 2026, she exercised employee stock options for multiple blocks of 4,129 common shares at exercise prices of $15.80 and $15.93 per share.
On February 5–6, 2026, she sold several blocks of Ensign common stock at weighted average prices ranging from about $185.22 to $197.21 per share under a Rule 10b5-1 trading plan adopted on September 12, 2025. After these transactions, she directly owned 272,889 common shares and indirectly held 56,340 shares through the Eric and Suzanne Snapper Family Trust.
Baillie Gifford & Co has filed a Schedule 13G reporting beneficial ownership of 4,569,254 shares of Ensign Group, Inc. common stock, or about 7.89% of the class, as of December 31, 2025.
Baillie Gifford reports sole voting power over 3,924,777 shares and sole dispositive power over all 4,569,254 shares, with no shared voting or dispositive power. The filing states the securities are held in the ordinary course of business on behalf of investment advisory clients and not for the purpose of changing or influencing control of Ensign Group.
A holder of ENSG common stock filed a notice to sell 375 shares under Rule 144. The shares were acquired through restricted stock vesting on 07/15/2021 as compensation from the issuer. The planned sale, via Fidelity Brokerage Services on NASDAQ, has an aggregate market value of 74250.00 based on the filing. The issuer had 58,112,780 shares outstanding when this notice was prepared.
A shareholder has filed a notice of proposed sale of 100 shares of common stock under Rule 144. The shares are planned to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 02/09/2026 and an aggregate market value of $19,800.00.
The 100 shares were acquired from the issuer on 01/15/2026 through restricted stock vesting as compensation, with payment also dated 01/15/2026. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.
A shareholder filed a notice of intent to sell 4,573 shares of common stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of 896,823.73.
The shares come from recent option exercises: 2,268 shares acquired on 02/06/2026 from an option granted on 08/31/2016, and 2,305 shares acquired on 02/05/2026 from an option granted on 05/25/2017, both paid in cash.
During the past three months, Suzanne Snapper sold 8,258 common shares on 02/05/2026 for gross proceeds of 1,606,055.89, as disclosed in the same notice.
An affiliated holder of ENSG has filed a notice of proposed sale of restricted securities. The filing covers 8,258 common shares, with an aggregate market value of $1,606,055.64, to be sold on or about 02/05/2026 on the NASDAQ through Fidelity Brokerage Services.
The shares consist of 4,129 shares from stock options granted on 08/31/2016 and 4,129 shares from options granted on 05/25/2017, all acquired and paid for in cash on 02/05/2026. The seller represents they are not aware of any undisclosed material adverse information about ENSG’s current or prospective operations.